Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03032159 · ClinicalTrials.gov registry record · NA
Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities
A NA study of Asthma, sponsored by Seattle Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 221
- Enrollment target
- 2
- Study locations
NCT03032159: Completed NA study of Asthma, sponsored by Seattle Children's Hospital.
NCT03032159 is a NA study of Asthma that has completed, run by Seattle Children's Hospital. The registered enrollment target is 221 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03032159, a NA study of Asthma, has completed, sponsored by Seattle Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 221 participants
- Enrollment target
- 2
- Study locations
Study Summary
Text2Breathe (T2B) is a randomized controlled trial aimed at improving communication between parents and their children's' primary care providers about asthma. The overarching goal of this study is to reduce disparities among a population with high rates of pediatric asthma morbidity. The investigators are testing the efficacy of a short message service (SMS)-enhanced health communication (HC) intervention ("Text2Breathe") designed to equip urban, low-income parents with tools for communicating effectively with their children's primary care provider (PCP).
Primary Outcome
Number of emergency department visits for asthma care
Conditions Studied
Interventions
- BEHAVIORAL Text2Breathe Study Group
Study Locations (2)
Washington
- Seattle Children's - Seattle
- Mary Bridge Children's Hospital at Multi Care Health System - Tacoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2015-08 |
| Est. Completion | 2020-03 |
| Phase | NA |
What the finished NCT03032159 record still lists
NCT03032159 is an interventional study that assigns participants to a tested intervention. The registered 221 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Text2Breathe Study Group is the first listed.
NCT03032159 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT03032159 about?
NCT03032159 is a clinical study titled "Text2Breathe: Enhance Parent Communication to Reduce Pediatric Asthma Disparities". Text2Breathe (T2B) is a randomized controlled trial aimed at improving communication between parents and their children's' primary care providers about asthma. The overarching goal of this study is to reduce disparities among a population with high rates of pediatric asthma morbidity. The investigat...
What is the current status of trial NCT03032159?
This trial is currently completed. It is a NA study. The enrollment target is 221 participants. The study started on 2015-08. Estimated completion is 2020-03.
What conditions does trial NCT03032159 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT03032159?
The interventions under investigation include: Text2Breathe Study Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03032159?
This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03032159 being conducted?
This trial has 2 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03032159's enrollment target sits among peer trials
221 153rd of 374 higher than 222 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03170440 · 221 participants · NA
Non-invasive Nerve Stimulation for PTSD and Sleep
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia